Skip to main content
Terug
Watch Compare

InspireMD, Inc.

Datakwaliteit: 100%
NSPR
NASDAQ Manufacturing Measuring & Analyzing Instruments
€ 1,29
▼ € 0,02 (-1,53%)
Marktkapitalisatie: 61,66 M
Prijs
€ 1,32
Marktkapitalisatie
61,66 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue grew 18,88% annually over 5 years — strong growth
Negative free cash flow of -36,77 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 9,23%

Groei

Revenue Growth (5Y)
18,88%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)28,11%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-115,67%
Onder sectorgemiddelde (-54,01%)
ROIC-85,27%
Net Margin-543,33%
Op. Margin-552,56%

Veiligheid

Debt / Equity
N/A
Current Ratio6,51
Interest CoverageN/A

Waardering

PE (TTM|NTM)
-1,26 | -2,13
Boven sectorgemiddelde (-1,49)
P/B Ratio0,96
EV/EBITDA0,00
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E -1,3 -1,5
P/B 1,0 1,6
ROE % -115,7 -54,0
Net Margin % -543,3 -41,5
Rev Growth 5Y % 18,9 1,8
D/E — 0,3

Koersdoel Analisten

3 analisten
Strong Buy
Huidig
€ 1,29
+287.6%
Koersdoel
€ 5,00
€ 4,00
€ 5,00
€ 6,00
Vooruitzicht
Forward K/W -2,13
Forward WPA -€ 0,61
Omzet Sch. 27,18 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 0,61
-€ 0,65 – -€ 0,55
 27,18 M 3
FY2026 -€ 0,73
-€ 0,76 – -€ 0,70
 13,91 M 3

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,19 -€ 0,14 +27,6%
Q32025 -€ 0,20 -€ 0,17 +12,8%
Q22025 -€ 0,26 -€ 0,26 0,0%
Q12025 -€ 0,20 -€ 0,22 -10,0%

All Fundamental Metrics
Growth
Revenue Growth (1Y) 28,11% Revenue Growth (3Y) 20,29%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 18,88% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 8,98 M Net Income (TTM) -48,79 M
ROE -115,67% ROA -87,26%
Gross Margin 29,50% Operating Margin -552,56%
Net Margin -543,33% Free Cash Flow (TTM) -36,77 M
ROIC -85,27% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 6,51
Interest Coverage N/A Asset Turnover 0,16
Working Capital 59,58 M Tangible Book Value 64,11 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,26 Forward P/E -2,13
P/B Ratio 0,96 P/S Ratio 6,87
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 0,00 Fwd EV/EBITDA N/A
Forward P/S 2,27 Fwd Earnings Yield N/A
FCF Yield -59,63%
Market Cap 61,66 M Enterprise Value -1,75 M
Per Share
EPS (Diluted TTM) -0,76 Revenue / Share 0,19
FCF / Share -0,79 OCF / Share -0,75
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 18,51% FCF Conversion 75,36%
SBC-Adj. FCF -48,69 M Growth Momentum 9,23

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 8,98 M 7,01 M 6,21 M 5,17 M 4,50 M
Net Income -48,79 M -32,01 M -19,92 M -18,49 M -14,92 M
EPS (Diluted) -0,76 -0,76 -0,82 — —
Gross Profit 2,65 M 1,51 M 1,81 M 1,12 M 754.000,0
Operating Income -49,61 M -33,50 M -21,14 M -18,71 M -14,72 M
EBITDA — — — — —
R&D Expenses 15,00 M 13,63 M 7,98 M 7,81 M 5,16 M
SG&A Expenses — — — — —
D&A 476,00 M 280,00 M 232,00 M 188.000,0 161.000,0
Interest Expense — — — — —
Income Tax 63.000,0 59.000,0 65.000,0 28.000,0 45.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 69,40 M 46,81 M 47,64 M 24,65 M 39,71 M
Total Liabilities 14,20 M 10,72 M 8,14 M 7,26 M 6,18 M
Shareholders' Equity 55,20 M 36,09 M 39,50 M 17,39 M 33,53 M
Total Debt — — — — —
Cash & Equivalents 8,94 M 18,92 M 9,64 M 4,63 M 12,00 M
Current Assets 61,47 M 40,52 M 44,16 M 21,33 M 37,09 M
Current Liabilities 10,71 M 7,68 M 6,02 M 5,07 M 4,35 M